108462-95-9

Basic information

• Product Name: 2-(4-CHLORO-BENZOYLAMINO)-PROPIONIC ACID
• Synonyms: 2-[(4-CHLOROBENZOYL)AMINO]PROPANOIC ACID;2-(4-CHLORO-BENZOYLAMINO)-PROPIONIC ACID;IFLAB-BB F1130-0065;2-[(4-chlorophenyl)formamido]propanoic acid
• CAS NO: 108462-95-9
• Molecular Formula: C₁₀H₁₀ClNO₃
• Molecular Weight: 227.64
• Mol File: 108462-95-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-(4-CHLORO-BENZOYLAMINO)-PROPIONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-CHLORO-BENZOYLAMINO)-PROPIONIC ACID(108462-95-9)
• EPA Substance Registry System: 2-(4-CHLORO-BENZOYLAMINO)-PROPIONIC ACID(108462-95-9)

Safety Data

• Hazardous Substances Data: 108462-95-9(Hazardous Substances Data)

Usage

Explanation

This is the chemical name of the compound, also known as carprofen.

Explanation

Carprofen belongs to a class of drugs called NSAIDs, which are used to reduce inflammation and pain.

Explanation

Carprofen is mainly used to alleviate pain and inflammation in veterinary patients, specifically dogs and cats.

Explanation

Carprofen works by inhibiting the production of prostaglandins, which are chemicals responsible for causing inflammation and pain.

Explanation

Carprofen is often prescribed to treat various conditions that involve pain and inflammation, such as arthritis, pain after surgery, and injuries to muscles and bones.

Explanation

Carprofen can be administered to animals in different forms, including tablets, chewable tablets for easier consumption, and injections for faster action.

Explanation

Carprofen is usually safe for animals when administered according to a veterinarian's guidance.

Explanation

As with other nonsteroidal anti-inflammatory drugs, carprofen may cause adverse effects, and it is essential to monitor the animal's response to the medication.

Explanation

To ensure the safe and effective use of carprofen, it is crucial to follow a veterinarian's recommendations and monitor the animal's response to the drug.

Classification

Nonsteroidal anti-inflammatory drug (NSAID)

Primary Use

Pain reliever and anti-inflammatory agent for dogs and cats

Mechanism of Action

Inhibition of prostaglandin production

Common Uses

Management of pain and inflammation associated with arthritis, post-operative pain, and musculoskeletal injuries

Available Forms

Tablets, chewable tablets, and injection

Safety and Tolerance

Generally well tolerated when used as directed by a veterinarian

Potential Side Effects

Like other NSAIDs, carprofen can have side effects

Veterinary Supervision

Important to use under veterinary supervision

Upstream product

• 122-01-0 4-chloro-benzoyl chloride 
• 302-72-7 rac-Ala-OH 
• 56-41-7 L-alanin 
• 128062-24-8 rac-ethyl 2-(4-chlorobenzamido)propanoate 

Downstream Products

• 108463-00-9 4-Chloro-N-(1-cyclohexyl-3,4-dimethyl-2-oxo-1,2,3,4-tetrahydro-pyridin-3-yl)-benzamide 
• 138111-75-8 D,L-N-(3-Methoxy propyl)-N-pentyl-2-(4-chlorobenzoyl amino)-propionamide 
• 22887-54-3 rac-2-(4-chlorophenyl)-4-methyloxazol-5(4H)-one 
• 478066-13-6 methyl 2-(4-chlorophenyl)-4-methyloxazole-5-carboxylate 
• 1423044-83-0 (R)-2-(4-chlorophenyl)-4-methyl-4-((R)-3-oxo-1-phenylbutyl)oxazol-5(4H)-one 
• 1565852-71-2 2-(4-chlorophenyl)-4-methyl-4-(2-(trimethylsilyl)ethynyl)oxazol-5(4H)-one 

Relevant articles and documents

Bronsted acid accelerated Pd-catalyzed direct asymmetric allylic alkylation of azlactones with simple allylic alcohols: A practical access to quaternary allylic amino acid derivatives

A Bronsted acid accelerated Pd-catalyzed asymmetric allylic alkylation of azlactones with simple allylic alcohols under mild reaction conditions has been realized, which provides a direct and readily scalable approach for the synthesis of all-carbon quaternary allylic amino acid derivatives in excellent yields and good enantioselectivities. (Chemical Equation Presented).

PYRROLONE MELANIN CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS

The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I wherein R1, Formula Ia, R4, R5, Formula Ib, R3, R3a, W, D, R2a, R2b and R2c are defined herein. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression, anxiety or intestinal inflammation, by administration of a therapeutically effective dose of a compound according to Formula I.

1-Azadienes in Heterocyclic Synthesis. Reaction of 1-N-Alkyl-1-azapenta-1,3-dienes with Mesoionic Oxazolones

1-N-Alkyl-1-azapenta-1,3-dienes 2 smoothly reacted with various mesoionic oxazolones 1 to afford 3,4-dihydro-2-pyridones 3 in excellent yields and there is no evidence for the formation of any products arising from the cycloaddition on the carbon-carbon double bond or on the azomethine function.